首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   193211篇
  免费   17492篇
  国内免费   8583篇
耳鼻咽喉   2553篇
儿科学   4586篇
妇产科学   2283篇
基础医学   32834篇
口腔科学   6026篇
临床医学   15789篇
内科学   26296篇
皮肤病学   4828篇
神经病学   10809篇
特种医学   4871篇
外国民族医学   122篇
外科学   17622篇
综合类   28610篇
现状与发展   53篇
预防医学   5600篇
眼科学   3730篇
药学   16786篇
  46篇
中国医学   5670篇
肿瘤学   30172篇
  2024年   417篇
  2023年   2881篇
  2022年   5115篇
  2021年   7162篇
  2020年   6289篇
  2019年   5976篇
  2018年   6118篇
  2017年   6422篇
  2016年   6731篇
  2015年   7657篇
  2014年   11245篇
  2013年   12607篇
  2012年   10755篇
  2011年   12002篇
  2010年   9926篇
  2009年   9439篇
  2008年   10009篇
  2007年   10229篇
  2006年   9246篇
  2005年   8439篇
  2004年   7509篇
  2003年   6443篇
  2002年   5324篇
  2001年   4576篇
  2000年   3835篇
  1999年   3424篇
  1998年   3290篇
  1997年   3023篇
  1996年   2740篇
  1995年   2419篇
  1994年   2185篇
  1993年   1813篇
  1992年   1501篇
  1991年   1460篇
  1990年   1191篇
  1989年   1089篇
  1988年   1013篇
  1987年   839篇
  1986年   810篇
  1985年   1066篇
  1984年   942篇
  1983年   664篇
  1982年   770篇
  1981年   608篇
  1980年   530篇
  1979年   402篇
  1978年   291篇
  1977年   260篇
  1976年   200篇
  1975年   107篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
《Cancer cell》2021,39(11):1497-1518.e11
  1. Download : Download high-res image (282KB)
  2. Download : Download full-size image
  相似文献   
102.
《Cancer cell》2020,37(1):123-134.e5
  1. Download : Download high-res image (200KB)
  2. Download : Download full-size image
  相似文献   
103.
随着对肿瘤热疗和肿瘤免疫微环境(TIME)的深入研究,近年来热疗对TIME的作用越来越受到学者们的重视。本文就目前国内外研究进展,对热疗与TIME中几类主要免疫细胞和免疫相关细胞因子的影响及作用机制作一综述。全面而透彻的了解热疗对TIME的调控作用,有助于为肿瘤治疗提供新的思路和方法。  相似文献   
104.
105.
106.
《Vaccine》2016,34(24):2663-2670
Human metapneumovirus (HMPV) is a major cause of morbidity and mortality from acute lower respiratory tract illness, with most individuals seropositive by age five. Despite the presence of neutralizing antibodies, secondary infections are common and can be severe in young, elderly, and immunocompromised persons. Preclinical vaccine studies for HMPV have suggested a need for a balanced antibody and T cell immune response to enhance protection and avoid lung immunopathology. We infected transgenic mice expressing human HLA-A*0201 with HMPV and used ELISPOT to screen overlapping and predicted epitope peptides. We identified six novel HLA-A2 restricted CD8+ T cell (TCD8) epitopes, with M39–47 (M39) immunodominant. Tetramer staining detected M39-specific TCD8 in lungs and spleen of HMPV-immune mice. Immunization with adjuvant-formulated M39 peptide reduced lung virus titers upon challenge. Finally, we show that TCD8 from HLA-A*0201 positive humans recognize M39 by IFNγ ELISPOT and tetramer staining. These results will facilitate HMPV vaccine development and human studies.  相似文献   
107.
108.
《Molecular therapy》2020,28(6):1432-1441
  1. Download : Download high-res image (155KB)
  2. Download : Download full-size image
  相似文献   
109.
110.

Background

Partial nephrectomy (PN) is generally favored for cT1 tumors over radical nephrectomy (RN) when technically feasible. However, it can be unclear whether the additional risks of PN are worth the magnitude of renal function benefit.

Objective

To develop preoperative tools to predict long-term estimated glomerular filtration rate (eGFR) beyond 30 d following PN and RN, separately.

Design, setting, and participants

In this retrospective cohort study, patients who underwent RN or PN for a single nonmetastatic renal tumor between 1997 and 2014 at our institution were identified. Exclusion criteria were venous tumor thrombus and preoperative eGFR <15 ml/min/1.73 m2.

Intervention

RN and PN.

Outcome measurements and statistical analysis

Hierarchical generalized linear mixed-effect models with backward selection of candidate preoperative features were used to predict long-term eGFR following RN and PN, separately. Predictive ability was summarized using marginal RGLMM2, which ranges from 0 to 1, with higher values indicating increased predictive ability.

Results and limitations

The analysis included 1152 patients (13 206 eGFR observations) who underwent RN and 1920 patients (18 652 eGFR observations) who underwent PN, with mean preoperative eGFRs of 66 ml/min/1.73 m2 (standard deviation [SD] = 18) and 72 ml/min/1.73 m2 (SD = 20), respectively. The model to predict eGFR after RN included age, diabetes, preoperative eGFR, preoperative proteinuria, tumor size, time from surgery, and an interaction between time from surgery and age (marginal RGLMM2=0.41). The model to predict eGFR after PN included age, presence of a solitary kidney, diabetes, hypertension, preoperative eGFR, preoperative proteinuria, surgical approach, time from surgery, and interaction terms between time from surgery and age, diabetes, preoperative eGFR, and preoperative proteinuria (marginal RGLMM2). Limitations include the lack of data on renal tumor complexity and the single-center design; generalizability needs to be confirmed in external cohorts.

Conclusions

We developed preoperative tools to predict renal function outcomes following RN and PN. Pending validation, these tools should be helpful for patient counseling and clinical decision-making.

Patient summary

We developed models to predict kidney function outcomes after partial and radical nephrectomy based on preoperative features. This should help clinicians during patient counseling and decision-making in the management of kidney tumors.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号